Social media

ICON’s Mia Carter joins a panel on Investigational Drug Accountability Management to discuss the real-world friction between clinical sites and sponsors and how to overcome it. Topics include regulatory alignment, effici...

Why do stability studies matter in early drug development? From shelf-life determination to regulatory readiness, a well-designed stability program ensures your drug product remains safe, effective, and reliable. Learn...

ICON will participate in the upcoming Medical Technology Enterprise Consortium (MTEC) webinar on 15 October from 1:00 pm to 2:00 pm. Timothy Bradshaw, Ph.D. and Edward Wright will speak on the topic: "Advancing ICON ea...

Connect with the ICON team during ACR Convergence 2025 at booth \#1501, to discover how Accellacare—our Global Site Network with deep expertise in osteoarthritis, osteoporosis, and rheumatoid arthritis—supports sponsors ...

Biosimilars are gaining ground in APAC — but adoption depends on education. ICON’s latest blog dives into the real-world barriers to biosimilar uptake across Asia-Pacific, from low patient awareness to prescriber miscon...

Biosimilars are positively impacting healthcare in APAC — but awareness and trust remain critical hurdles. ICON explores how strategic education and engagement can unlock biosimilar adoption across Asia-Pacific, from em...

More than 100 million people in the US have some form of liver disease. On November 7-11, meet the ICON team at AASLD, booth \#1041 to learn how we apply flexible partnership and delivery models, supported by robust to...

From a small-town GP to Site Head at ICON Bulgaria, Dimitar Karzhin’s story is one of purpose, growth, and community. Since joining ICON in 2011, Dimitar has seen our Bulgaria operations expand from a remote team of jus...

R, an open-source programming language for statistical computing, is transforming the role of clinical programmers. It enables reproducible research, supports cross team collaboration, and strengthens regulatory complian...

Join us at ACoP 2025 for two in-person workshops on October 17th, designed to help you build confidence and gain practical tools for delivering impactful NONMEM presentations. Workshop 1 : New and advanced features of N...

Pediatric clinical trials have different processes, risks and challenges than adult trials. Identifying those differences is critical but can be difficult, especially if resources are limited. Join ICON’s Heather Peterso...

Clinical development processes for pediatric trials differ from adult trials. Register for our webinar to learn about regulatory strategies and tools needed to ensure pediatric access to medical treatment and an interact...